Skip to main content
. 2016 Feb 21;28(6):1591–1606. doi: 10.1021/acs.chemmater.5b04281

Figure 15.

Figure 15

(a) Structure of paclitaxel–polylactide (Ptx-PLA) and formation of KLWVLPK peptide-functionalized lipid–polymer hybrid nanoparticles composed of a Ptx-PLA core and a PEGylated lipidic shell. (b) Human aortic smooth muscle cell (haSMC) cytotoxicity study showing the targeted drug release from KLWVLPK peptide-functionalized hybrid nanoparticles. Adapted with permissions from ref (79).